Showing results (1-10 of 56) with videos related to

Sort By:
Pageof 6
Frontiers in Neurology|June 22, 2018
Are We Ready for Detecting α-Synuclein Prone to Aggregation in Patients? The Case of "Protein-Misfolding Cyclic Amplification" and "Real-Time Quaking-Induced Conversion" as Diagnostic ToolsSilvia Paciotti, Giovanni Bellomo, Leonardo Gatticchi, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|November 16, 2019
The vicious cycle between α-synuclein aggregation and autophagic-lysosomal dysfunctionGiovanni Bellomo, Silvia Paciotti, Leonardo Gatticchi, et al.
Expert Review of Molecular Diagnostics|September 12, 2024
Research advancement in fluid biomarkers for Parkinson's diseaseLorenzo Gaetani, Federico Paolini Paoletti, Alessandro Mechelli, et al.
Expert Review of Molecular Diagnostics|October 30, 2023
Required improvements for cerebrospinal fluid-based biomarker tests of Alzheimer's diseaseLorenzo Gaetani, Davide Chiasserini, Federico Paolini Paoletti, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|May 4, 2019
Parkinson's and Lewy body dementia CSF biomarkersLucilla Parnetti, Silvia Paciotti, Lucia Farotti, et al.
Journal of Translational Medicine|January 28, 2025
Studying Alzheimer's disease through an integrative serum metabolomic and lipoproteomic approachAlessia Vignoli, Giovanni Bellomo, Federico Paolini Paoletti, et al.
Alzheimer'S Research & Therapy|September 30, 2020
Measurement of CSF core Alzheimer disease biomarkers for routine clinical diagnosis: do fresh vs frozen samples differ?Giovanni Bellomo, Samuela Cataldi, Silvia Paciotti, et al.
Cells|August 27, 2021
Neuroinflammation and Alzheimer's Disease: A Machine Learning Approach to CSF ProteomicsLorenzo Gaetani, Giovanni Bellomo, Lucilla Parnetti, et al.
Clinical Chemistry and Laboratory Medicine|September 1, 2023
CSF and plasma Aβ42/40 across Alzheimer's disease continuum: comparison of two ultrasensitive Simoa® assays targeting distinct amyloid regionsAnna Lidia Wojdała, Giovanni Bellomo, Andrea Toja, et al.
Nature Communications|January 3, 2025
Immunoassay detection of multiphosphorylated tau proteoforms as cerebrospinal fluid and plasma Alzheimer's disease biomarkersAnna L Wojdała, Giovanni Bellomo, Lorenzo Gaetani, et al.
Pageof 6